Ahmet Cingöz

460 total citations
18 papers, 315 citations indexed

About

Ahmet Cingöz is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ahmet Cingöz has authored 18 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Ahmet Cingöz's work include RNA Interference and Gene Delivery (6 papers), Cell death mechanisms and regulation (5 papers) and Glioma Diagnosis and Treatment (3 papers). Ahmet Cingöz is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Cell death mechanisms and regulation (5 papers) and Glioma Diagnosis and Treatment (3 papers). Ahmet Cingöz collaborates with scholars based in Türkiye, United States and Canada. Ahmet Cingöz's co-authors include Tugba Bagcı-Önder, Fidan Seker-Polat, İlknur Sur‐Erdem, Nathan A. Lack, Ezgi Kaya-Aksoy, Seda Kızılel, Pelin Erkoc, Zeynep H. Gümüş, Tamer T. Önder and Mehmet Gönen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Ahmet Cingöz

17 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmet Cingöz Türkiye 11 190 63 45 38 38 18 315
Fidan Seker-Polat United States 10 133 0.7× 82 1.3× 49 1.1× 74 1.9× 34 0.9× 14 351
Jaewan Jeon South Korea 11 139 0.7× 58 0.9× 97 2.2× 35 0.9× 28 0.7× 15 284
Youlim Son South Korea 8 193 1.0× 87 1.4× 69 1.5× 14 0.4× 46 1.2× 10 343
Hong Jin China 8 186 1.0× 78 1.2× 66 1.5× 13 0.3× 66 1.7× 13 333
Jingfeng Luo China 10 172 0.9× 50 0.8× 37 0.8× 25 0.7× 13 0.3× 25 328
Angana Biswas India 9 165 0.9× 25 0.4× 79 1.8× 35 0.9× 22 0.6× 14 255
Songyuan Li South Korea 15 331 1.7× 70 1.1× 26 0.6× 27 0.7× 15 0.4× 27 486
Alison Howarth United Kingdom 10 158 0.8× 34 0.5× 77 1.7× 18 0.5× 22 0.6× 16 285

Countries citing papers authored by Ahmet Cingöz

Since Specialization
Citations

This map shows the geographic impact of Ahmet Cingöz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Cingöz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Cingöz more than expected).

Fields of papers citing papers by Ahmet Cingöz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Cingöz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Cingöz. The network helps show where Ahmet Cingöz may publish in the future.

Co-authorship network of co-authors of Ahmet Cingöz

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Cingöz. A scholar is included among the top collaborators of Ahmet Cingöz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Cingöz. Ahmet Cingöz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cingöz, Ahmet, Buse Cevatemre, Martin Philpott, et al.. (2025). Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer. Experimental & Molecular Medicine. 57(6). 1294–1307. 2 indexed citations
2.
Çavdar, Safiye, et al.. (2023). Lymphatic vessels accompanying dorsal and basal dural sinuses in the human brain. Journal of Chemical Neuroanatomy. 134. 102357–102357. 4 indexed citations
3.
Cingöz, Ahmet, et al.. (2023). Directing chemiluminescent dioxetanes to mitochondria: A cationic luminophore enables in vitro and in vivo detection of cancer cells upon enzymatic activation. Sensors and Actuators B Chemical. 383. 133574–133574. 10 indexed citations
4.
Kayabölen, Alişan, Ahmet Cingöz, Tunç Morova, et al.. (2022). EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. Cell Death and Disease. 13(8). 710–710. 12 indexed citations
5.
Cingöz, Ahmet, Tunç Morova, Fidan Seker-Polat, et al.. (2021). Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene. 40(18). 3201–3216. 9 indexed citations
6.
Dogan, Nihal Olcay, Ugur Bozuyuk, Pelin Erkoc, et al.. (2021). Parameters Influencing Gene Delivery Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach. SHILAP Revista de lepidopterología. 2(1). 19 indexed citations
7.
Cingöz, Ahmet, et al.. (2020). Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma. Frontiers in Neuroscience. 14. 578316–578316. 3 indexed citations
8.
Sur‐Erdem, İlknur, Mine Altunbek, Fidan Seker-Polat, et al.. (2020). TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway. Neurological Research. 42(12). 1061–1069. 12 indexed citations
9.
Seker-Polat, Fidan, Ahmet Cingöz, İlknur Sur‐Erdem, et al.. (2019). Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling. Cancers. 11(11). 1651–1651. 46 indexed citations
10.
Sur‐Erdem, İlknur, Fidan Seker-Polat, Ahmet Cingöz, et al.. (2019). The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma. Cell Death and Disease. 10(12). 894–894. 26 indexed citations
11.
Morova, Tunç, Elisabete Pires, James McCullagh, et al.. (2019). Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer. Oncogene. 39(10). 2187–2201. 29 indexed citations
12.
Kaya-Aksoy, Ezgi, Ahmet Cingöz, Fidan Seker-Polat, et al.. (2019). The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme. Cell Death Discovery. 5(1). 64–64. 29 indexed citations
13.
Sur‐Erdem, İlknur, Ezgi Kaya-Aksoy, Ahmet Cingöz, et al.. (2017). KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL. Cell Death and Disease. 8(6). e2897–e2897. 30 indexed citations
14.
Erkoc, Pelin, Ahmet Cingöz, Tugba Bagcı-Önder, & Seda Kızılel. (2017). Macromol. Biosci. 2/2017. Macromolecular Bioscience. 17(2).
15.
Cingöz, Ahmet, et al.. (2017). Abstract 4164: TRAIL resistance of glioblastoma cells is associated with DNA damage signalling network. Cancer Research. 77(13_Supplement). 4164–4164. 1 indexed citations
16.
Cingöz, Ahmet, et al.. (2016). An exploration of plastic deformation dependence of cell viability and adhesion in metallic implant materials. Journal of the mechanical behavior of biomedical materials. 60. 177–186. 22 indexed citations
17.
Cingöz, Ahmet, Ezgi Kaya-Aksoy, Selena Kazancioglu, et al.. (2016). Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme. Cancer Biology & Therapy. 17(5). 546–557. 31 indexed citations
18.
Erkoc, Pelin, Ahmet Cingöz, Tugba Bagcı-Önder, & Seda Kızılel. (2016). Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers. Macromolecular Bioscience. 17(2). 1600267–1600267. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026